HOME   ABOUT US TECHNOLOGY  PRODUCTS  CONTACT US


Biohelix has moved to a new facility.

Quidel and BioHelix enter into a joint development and commercialization agreement.

BioHelix awarded a Cooperative Agreement with NIAID.

Dr. Heiner Dreismann joins BioHelix Board.

Publication on C. difficile
A spin-off from
  Privacy, Limitation, Warranty, Disclaimer